Employees: 03 (2023.0)Legal category: 5485Size: PMECreation date: 2014-04-22 (12 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: BASSENS ([ND]), None
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
PHARMACIE LAMBERT : revenue, balance sheet and financial ratios
PHARMACIE LAMBERT is a French company
founded 12 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in BASSENS ([ND]),
this company of category PME
shows in 2025 a net income positive of 138 k€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE LAMBERT (SIREN 801853805)
Indicator
2025
2023
2022
2021
2020
2019
2018
2017
Revenue
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Net income
138 234 €
114 852 €
113 624 €
136 183 €
92 055 €
82 809 €
94 713 €
92 846 €
EBITDA
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Net margin
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Revenue and income statement
In 2025, PHARMACIE LAMBERT generates positive net income of 138 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2017-2025: 93 k€ -> 138 k€.
Net income (2025)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
138 234 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 22%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 71%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2025)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
22.39%
Financial autonomy (2025)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
71.061%
Asset age ratio (2025)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2017
2018
2019
2020
2021
2022
2023
2025
Debt ratio
319.702
233.185
188.406
145.86
106.06
116.367
74.117
22.39
Financial autonomy
20.961
27.593
32.212
37.162
42.04
39.827
49.962
71.061
Repayment capacity
None
None
None
None
None
None
None
None
Cash flow / Revenue
None%
None%
None%
None%
None%
None%
None%
None%
Sector positioning
Debt ratio
22.392025
2022
2023
2025
Q1: 13.71
Med: 49.76
Q3: 129.07
Good-29 pts over 3 years
In 2025, the debt ratio of PHARMACIE LAMBERT (22.39) ranks below the median of the sector. This ratio measures the weight of debt relative to equity. This controlled position reflects prudent management.
Financial autonomy
71.06%2025
2022
2023
2025
Q1: 33.42%
Med: 53.71%
Q3: 72.08%
Good+33 pts over 3 years
In 2025, the financial autonomy of PHARMACIE LAMBERT (71.1%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 195.83. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2025)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
195.834
Liquidity indicators evolution PHARMACIE LAMBERT
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2017
2018
2019
2020
2021
2022
2023
2025
Liquidity ratio
164.091
220.627
265.069
225.472
184.364
297.578
264.892
195.834
Interest coverage
None
None
None
None
None
None
None
None
Sector positioning
Liquidity ratio
195.832025
2022
2023
2025
Q1: 131.03
Med: 182.29
Q3: 258.7
Good-21 pts over 3 years
In 2025, the liquidity ratio of PHARMACIE LAMBERT (195.83) ranks above the median of the sector. This ratio measures the ability to cover short-term debt with current assets. This comfortable position offers an appreciable safety margin.
Positioning of PHARMACIE LAMBERT in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 277 transactions of similar company sales
in 2025,
the value of PHARMACIE LAMBERT is estimated at
2 195 863 €
(range 1 490 123€ - 3 445 612€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2025
277 transactions
1490k€2195k€3445k€
2 195 863 €Range: 1 490 123€ - 3 445 612€
NAF 5 année 2025
Valuation method used
Net Income Multiple
138 234 €
×
15.9x
=2 195 864 €
Range: 1 490 123€ - 3 445 612€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 277 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE LAMBERT with other companies in the same sector:
Frequently asked questions about PHARMACIE LAMBERT
What is the revenue of PHARMACIE LAMBERT ?
The revenue of PHARMACIE LAMBERT is not publicly disclosed (confidential accounts filed with INPI).
Is PHARMACIE LAMBERT profitable?
Yes, PHARMACIE LAMBERT generated a net profit of 138 k€ in 2025.
Where is the headquarters of PHARMACIE LAMBERT ?
The headquarters of PHARMACIE LAMBERT is located in BASSENS ([ND]).
Where to find the tax return of PHARMACIE LAMBERT ?
The tax return of PHARMACIE LAMBERT is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE LAMBERT operate?
PHARMACIE LAMBERT operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart